ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 12.10
+0.05 (0.41%)
Dec 29, 2025, 4:20 PM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 112.31 million as of December 29, 2025. Its market cap has increased by 7.56% in one year.
Market Cap
112.31M
Enterprise Value
107.97M
Revenue
8.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.10
Market Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 112.31M, a decrease of -56.67%. That is a compound annual growth rate of -10.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 111.85M | 36.42% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.47T |
| Genmab | 130.78B |
| Coloplast | 122.33B |
| ALK-Abelló | 50.34B |
| Demant | 45.59B |
| H. Lundbeck | 41.13B |
| Zealand Pharma | 33.95B |
| Ambu A/S | 23.39B |